EMA — authorised 18 September 2017
- Marketing authorisation holder: Merck Europe B.V.
- Status: approved
🇪🇺 Bavencio in European Union
EMA authorised Bavencio on 18 September 2017
Marketing authorisation
Bavencio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Bavencio approved in European Union?
Yes. EMA authorised it on 18 September 2017.
Who is the marketing authorisation holder for Bavencio in European Union?
Merck Europe B.V. holds the EU marketing authorisation.